Deep learning classifies Alzheimer’s for personalized diagnosis, risk prediction

An AI algorithm has slightly outperformed neurologists at identifying or ruling out Alzheimer’s disease from MRI brain scans combined with demographic information and neuropsychological test results.

Developed by researchers at Boston University, the novel deep learning model is described in an open-access study running in Brain.

In internal coverage of the science published by the school, computational biomedicine specialist Vijaya Kolachalama, PhD, and colleagues suggest the study results show the field is closing in on the ability to predict Alzheimer’s risk at the point of care.

“If we have accurate tools to predict the risk of Alzheimer’s disease that are readily available and can use routinely available data such as a brain MRI scan, [the technology] will have the potential to assist clinical practice, especially in memory clinics.”

Click here to read the news item and here for the study.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup